04 Dec 2023 by admin in UncategorizedComments Zenas BioPharma Strengthens Executive Leadership with Appointment of Jennifer Fox as Chief Business Officer and Chief Financial Officer and Tanya Fischer, M.D., PhD. as Head of R&D and Chief Medical Officer
15 Nov 2023 by admin in UncategorizedComments ARCELLX AND KITE ANNOUNCE EXPANSION IN STRATEGIC PARTNERSHIP
19 Oct 2023 by admin in UncategorizedComments Flagship Pioneering Announces the Merger of Two Leading Programmable Medicine Platforms to form Sail
02 Oct 2023 by admin in UncategorizedComments Syros Announces Planned CEO Leadership Transition and Strategic Reorganization to Support Long-Term Business Growth and Maturation into a Commercial Biopharmaceutical Company
19 Sep 2023 by admin in UncategorizedComments Tempest Announces Expanded Role for Sam Whiting, M.D., Ph.D., as Chief Medical Officer and Head of Research and Development
12 Sep 2023 by admin in UncategorizedComments Kira Pharmaceuticals Presents Complete Data from Phase 1 SYNERGY-1 Trial of KP104 and Preclinical Studies in Autoimmune Skin Disease Models from Collaboration with University of Lübeck at the 29th International Complement Workshop (ICW 2023)
07 Sep 2023 by admin in UncategorizedComments NextCure and Nordic Bioscience Publish Review Article on the Regulation of Tumor Immunity by Tumor Collagen
05 Sep 2023 by admin in UncategorizedComments Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb
04 Sep 2023 by admin in UncategorizedComments Crescendo Biologics Wins Significant European Patent Office Ruling Related to the Engineering of Immunoglobulin Therapeutics
18 Aug 2023 by admin in UncategorizedComments Eluminex Biosciences Completes Series B+ Financing, Raising More Than $50 M in 2023
